Global Ganja Report

Deputy Attorney General James Cole, the same who authored a notorious 2011 memo asserting that federal cannabis enforcement remains a "core priority" even in states that have passed medical marijuana laws, has just issued a new memorandum seeming to clarify Justice Department reaction to the legalization measures in Colorado and Washington state. While it is written in the usual dense bureaucratese that often hides as much as it reveals, on balance it appears to represent a retreat from the hardline posture the Obama administration has assumed regarding medicinal cannabis over the past two years. The text of the Aug. 29 memo is provided by our comrades at CelebStoner:

Cannabis is a $1.65 billion industry in New York City, according to a report released Aug. 14 by comptroller and mayoral hopeful John Liu, with the potential to become a $1.7 billion industry if it were made legal in the Big Apple. The report is the first official estimate of the city's cannabis market, and the first study to consider the idea of legalization at the municipal level in the nation's biggest city.

Uruguay’s lower house July 31 approved a bill to legalize cannabis, by a vote of 50 to 46. The bill now goes to the Senate, where lawmakers have assured President José Mujica they have a majority to approve it. Mujica's administration introduced the bill, and his signature is not in doubt. Laura Blanco, president of Uruguay's Cannabis Studies Association said the bill sent an "encouraging" sign to other Latin American nations.  Under the law, citizens will be allowed to  cultivate cannabis in their homes, limited to six plants per household. They would also be permitted to form cooperatives allowed to grow 99 plants. In addition, private companies can produce under the bill, their harvests to be bought by the government for resale to licensed pharmacies. To buy in pharmacies, citizens must submit their names into a  confidential federal registry, and are limited to buying 40 grams per month. In a move to prevent cannabis tourism, the legislation restricts legal purchases to Uruguayans.

Former Mexican president Vicente Fox last week presided over an international conference in his home state of Guanajuato, hosted by his private think-tank Centro Fox and dubbed the US-Mexico Symposium on Legalization and Medical Use of Cannabis. Joining Fox at the confab were ex-Microsoft executive James Shively, who plans to create the first US national marijuana brand, as well as a wide range of activists and academics that included former Mexican health minister Julio Frenk. Asked by Reuters whether Mexico could legalize cannabis by the time current president Enrique Peña Nieto's term ends in 2018, Fox said: "I think it's going to happen much sooner. Once California gets into this, Mexico is going to be obligated to speed up its decision process." (Reuters, July 24; Correo, Guanajuato, Latino Daily News, July 21; Reuters, El Universal, July 20)

More than 160 civil society organizations representing hundreds of thousands of citizens in Mexico, Central America and the United States, sent an open letter to the OAS General Assembly meeting in the Guatemalan city of Antigua this week,  calling for alternatives to the "war on drugs" that guarantee respect for human rights. "Our organizations have documented an alarming increase in violence and human rights violations. While we recognize that transnational crime and drug-trafficking play a role in this violence, we call on our governments to acknowledge that failed security policies that have militarized citizen security have only exacerbated the problem, and are directly contributing to increased human suffering in the region," the letter states.

As the  Organization of American States (OAS) summit opens under tight security in the historic Guatemalan city of Antigua—some 2,000 army and National Police troops deployed—fighting narco-trafficking is certain to top the agenda. Secretary of State John Kerry will be in attendance, with US Drug Czar Gil Kerlikowske—prepared to oppose initiatives to reconsider the "war on drugs," including from Guatemala's otherwise arch-conservative President Otto Pérez Molina. But it remains to be seen if the summit will take up the iconoclastic recommendations of a draft report on drug policy released by the OAS last month. When the ground-breaking report was issued, OAS Secretary-General José Miguel Insulza asserted, "this is not a conclusion but only the beginning of a long-awaited discussion." As the Guatemala summit opened June 3, he reiterated that the report will not be officially adopted by the international body, but that "it will be only a platform for discussion." This equivocation will doubtless be welcome in Washington, given the report's open dissidence from generations of "drug war" dogma.

Gov. John Hickenlooper of Colorado on May 28 signed a new set of laws regulating the use and sale of cannabis. One law, HB13-1317, expands the medical marijuana enforcement division to cover retail cannabis sales. The law also prohibits retail cannabis outlets from selling more than one-fourth of an ounce to non-residents. Another law, HB13-1318, still subject to voter approval in the November statewide election, imposes a 15% sales tax on retail cannabis or cannabis products, and allocates 10% of the total tax revenue among the state's local governments that have at least one retail cannabis outlet. A third law, HB13-1325, provides that motorists found to have blood levels of five nanograms or more of delta 9-tetrahydrocannabinol per milliliter may be charged for DUI.

Congressman Jared Polis (D-CO) introduced legislation last month, House Resolution 499, which would effectively end the federal prohibition on marijuana and allow states to set their own policies. The Ending Marijuana Prohibition Act of 2013 would remove cannabis from the Controlled Substances Act, transfer the Drug Enforcement Administration's authority to regulate the herb to a newly renamed Bureau of Alcohol, Tobacco, Marijuana and Firearms, require commercial producers to purchase a permit, and ensure that federal law distinguishes between individuals who grow for personal use and those involved in commercial sale and distribution. (NORML Action Alert)